EE9400346A - Galaniini antagonist, selle valmistamise protsess ja teda sisaldavad ravimpreparaadid - Google Patents
Galaniini antagonist, selle valmistamise protsess ja teda sisaldavad ravimpreparaadidInfo
- Publication number
- EE9400346A EE9400346A EE9400346A EE9400346A EE9400346A EE 9400346 A EE9400346 A EE 9400346A EE 9400346 A EE9400346 A EE 9400346A EE 9400346 A EE9400346 A EE 9400346A EE 9400346 A EE9400346 A EE 9400346A
- Authority
- EE
- Estonia
- Prior art keywords
- galanin
- pro
- preparation process
- pharmaceutical preparations
- preparations containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/70—Enkephalins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/18—Kallidins; Bradykinins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9101472A SE9101472D0 (sv) | 1991-05-15 | 1991-05-15 | Galanin antagonist |
Publications (1)
Publication Number | Publication Date |
---|---|
EE9400346A true EE9400346A (et) | 1996-04-15 |
Family
ID=20382742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EE9400346A EE9400346A (et) | 1991-05-15 | 1994-11-03 | Galaniini antagonist, selle valmistamise protsess ja teda sisaldavad ravimpreparaadid |
Country Status (24)
Country | Link |
---|---|
EP (2) | EP0585300B1 (et) |
JP (1) | JPH06507629A (et) |
KR (1) | KR100221769B1 (et) |
AT (1) | ATE149525T1 (et) |
AU (1) | AU664180B2 (et) |
CA (1) | CA2109503A1 (et) |
CZ (1) | CZ242293A3 (et) |
DE (2) | DE69217937T2 (et) |
DK (1) | DK0585300T3 (et) |
EE (1) | EE9400346A (et) |
ES (1) | ES2098510T3 (et) |
FI (1) | FI935010A (et) |
GR (1) | GR3023150T3 (et) |
HU (1) | HUT65810A (et) |
IE (1) | IE921555A1 (et) |
IS (1) | IS3866A (et) |
NO (1) | NO934098D0 (et) |
PL (1) | PL171497B1 (et) |
SE (1) | SE9101472D0 (et) |
SG (1) | SG43921A1 (et) |
SI (1) | SI9200081B (et) |
SK (1) | SK127793A3 (et) |
WO (1) | WO1992020709A1 (et) |
YU (1) | YU50592A (et) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL107400A0 (en) * | 1992-11-10 | 1994-01-25 | Cortech Inc | Bradykinin antagonists |
FR2716205B1 (fr) * | 1994-02-17 | 1996-04-12 | Rhone Poulenc Rorer Sa | Récepteur galanine, acides nucléiques, cellules transformées et utilisations. |
US5972624A (en) * | 1996-01-24 | 1999-10-26 | Synaptic Pharmaceutical Corporation | Method of identifying ligands which bind recombinant galanin receptor (GALR2) |
DE819167T1 (de) | 1996-01-24 | 1998-04-09 | Synaptic Pharma Corp | Dns codierend für galanin galr2 rezeptoren und deren verwendung |
DK1342410T3 (da) | 1996-07-24 | 2010-05-31 | Neurotargets Ltd | Anvendelse af en galaninagonist til fremstilling af et medikament til forbedring af hukommelse og andre kognitive funktioner |
US6329197B2 (en) | 1996-10-09 | 2001-12-11 | Synaptic Pharmaceutical Corporation | DNA encoding galanin GALR3 receptors and uses thereof |
WO1999005302A1 (en) * | 1997-07-24 | 1999-02-04 | The Perkin-Elmer Corporation | Conjugates of transporter peptides and nucleic acid analogs, and their use |
DE69925116T2 (de) | 1998-03-25 | 2005-11-17 | Takeda Pharmaceutical Co. Ltd. | Neue, physiologisch aktive peptide und ihre verwendung. |
WO2000071533A2 (en) * | 1999-05-21 | 2000-11-30 | Ortho-Mcneil Pharmaceutical, Inc. | 1,4-dithiin and 1,4-dithiepin- 1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor |
US6407136B1 (en) | 1999-05-21 | 2002-06-18 | Ortho-Mcneil Pharmaceutical, Inc. | 1,4-dithiin and 1,4-dithiepin-1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor |
EP1089439A1 (en) * | 1999-09-28 | 2001-04-04 | TELEFONAKTIEBOLAGET L M ERICSSON (publ) | Interleaver and method for interleaving an input data bit sequence using a coded storing of symbol and additional information |
US7220775B2 (en) | 2002-08-07 | 2007-05-22 | H. Lundbeck A/S | Compound useful for the treatment of neuropathic pain |
WO2006047302A1 (en) | 2004-10-21 | 2006-05-04 | Transtech Pharma, Inc. | Bissulfonamide compounds as agonists of galr1, compositions, and methods of use |
GB0523550D0 (en) | 2005-11-18 | 2005-12-28 | Hunter Fleming Ltd | Therapeutic uses of steroidal compounds |
EP2913056A1 (en) * | 2006-01-05 | 2015-09-02 | The University of Utah Research Foundation | Methods and compositions related to improving properties of pharmacological agents targeting nervous system |
WO2010028673A1 (en) * | 2008-09-09 | 2010-03-18 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
WO2012082942A2 (en) | 2010-12-15 | 2012-06-21 | Neuroadjuvants, Inc. | Neuropeptide analogs, compositions, and methods for treating pain |
AU2014234400B2 (en) | 2013-03-21 | 2017-11-16 | Sanofi-Aventis Deutschland Gmbh | Synthesis of hydantoin containing peptide products |
ES2624961T3 (es) | 2013-03-21 | 2017-07-18 | Sanofi-Aventis Deutschland Gmbh | Síntesis de productos de péptido que contienen imida cíclica |
CN110055340B (zh) * | 2019-04-11 | 2021-01-01 | 中国农业大学 | 一种食品中牛源成分快速检测方法及试剂盒 |
-
1991
- 1991-05-15 SE SE9101472A patent/SE9101472D0/xx unknown
-
1992
- 1992-05-13 YU YU50592A patent/YU50592A/sh unknown
- 1992-05-14 SK SK1277-93A patent/SK127793A3/sk unknown
- 1992-05-14 AU AU17858/92A patent/AU664180B2/en not_active Ceased
- 1992-05-14 DK DK92910508.8T patent/DK0585300T3/da active
- 1992-05-14 AT AT92910508T patent/ATE149525T1/de not_active IP Right Cessation
- 1992-05-14 EP EP92910508A patent/EP0585300B1/en not_active Expired - Lifetime
- 1992-05-14 HU HU9303236A patent/HUT65810A/hu unknown
- 1992-05-14 CA CA002109503A patent/CA2109503A1/en not_active Abandoned
- 1992-05-14 EP EP19920850108 patent/EP0514361A1/en active Pending
- 1992-05-14 DE DE69217937T patent/DE69217937T2/de not_active Expired - Fee Related
- 1992-05-14 PL PL92301284A patent/PL171497B1/pl unknown
- 1992-05-14 CZ CS932422A patent/CZ242293A3/cs unknown
- 1992-05-14 KR KR1019930703433A patent/KR100221769B1/ko not_active IP Right Cessation
- 1992-05-14 WO PCT/SE1992/000316 patent/WO1992020709A1/en not_active Application Discontinuation
- 1992-05-14 ES ES92910508T patent/ES2098510T3/es not_active Expired - Lifetime
- 1992-05-14 SG SG1996005509A patent/SG43921A1/en unknown
- 1992-05-14 JP JP4510575A patent/JPH06507629A/ja active Pending
- 1992-05-14 DE DE0585300T patent/DE585300T1/de active Pending
- 1992-05-15 SI SI9200081A patent/SI9200081B/sl unknown
- 1992-05-15 IS IS3866A patent/IS3866A/is unknown
- 1992-07-01 IE IE155592A patent/IE921555A1/en unknown
-
1993
- 1993-11-12 NO NO1993934098A patent/NO934098D0/no not_active Application Discontinuation
- 1993-11-12 FI FI935010A patent/FI935010A/fi unknown
-
1994
- 1994-11-03 EE EE9400346A patent/EE9400346A/et unknown
-
1997
- 1997-04-15 GR GR970400812T patent/GR3023150T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU1785892A (en) | 1992-12-30 |
PL171497B1 (pl) | 1997-05-30 |
GR3023150T3 (en) | 1997-07-30 |
SI9200081A (en) | 1992-12-31 |
SK127793A3 (en) | 1994-04-06 |
ES2098510T3 (es) | 1997-05-01 |
SG43921A1 (en) | 1997-11-14 |
EP0585300A1 (en) | 1994-03-09 |
NO934098L (no) | 1993-11-12 |
CA2109503A1 (en) | 1992-11-16 |
FI935010A0 (fi) | 1993-11-12 |
DE585300T1 (de) | 1994-06-16 |
DE69217937D1 (de) | 1997-04-10 |
DE69217937T2 (de) | 1997-06-19 |
AU664180B2 (en) | 1995-11-09 |
NO934098D0 (no) | 1993-11-12 |
YU50592A (sh) | 1994-09-09 |
SE9101472D0 (sv) | 1991-05-15 |
IE921555A1 (en) | 1992-11-18 |
IS3866A (is) | 1992-11-16 |
JPH06507629A (ja) | 1994-09-01 |
DK0585300T3 (da) | 1997-09-01 |
WO1992020709A1 (en) | 1992-11-26 |
EP0585300B1 (en) | 1997-03-05 |
EP0514361A1 (en) | 1992-11-19 |
ATE149525T1 (de) | 1997-03-15 |
CZ242293A3 (en) | 1994-07-13 |
FI935010A (fi) | 1993-11-12 |
KR100221769B1 (ko) | 1999-10-01 |
SI9200081B (sl) | 2000-08-31 |
HUT65810A (en) | 1994-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE9400346A (et) | Galaniini antagonist, selle valmistamise protsess ja teda sisaldavad ravimpreparaadid | |
FI910286A0 (fi) | Analoger av humant insulin och preparat innehaollande dessa. | |
TW349867B (en) | Pharmaceutical composition for inducing a cytotoxic T-lymphocyte responses | |
DE69028671D1 (de) | Löslisches extrazellulares Fragment des menschlischen IFN-beta 2/IL-6-Rezeptors, seine Herstellung und diesen Fragment enthaltende pharmazeutische Mischung | |
ZA946142B (en) | Therapeutic heterocycles | |
BG95935A (bg) | Метод и средство за приемане на дексмедетомидин директно през кожата | |
DE69230670D1 (de) | Zusammensetzungen, die eine blutgerinnselpolymermatrix zur verabreichung von osteogenen proteinen enthalten | |
EP1233013A4 (en) | phenylalanine derivatives | |
NO871574D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive peptider. | |
ATE191719T1 (de) | Analoge des calcitonin aus lachs, ihre herstellung und ihre verwendung als medizin und als analytische reagentien | |
ES2059545T5 (es) | Hormonas de glicoproteinas modificadas por mutagenesis dirigida por puntos y metodos de uso de tales hormonas. | |
ES2157886T3 (es) | Composiciones tensioactivas y procedimientos. | |
SE8800080L (sv) | Laekemedelskomposition | |
NZ235497A (en) | Peptides (possibly related to hirudin) and pharmaceutical compositions for reducing blood coagulation | |
ATE253590T1 (de) | Peptide, bronchodilator und den blutstrom verbesserndes mittel | |
DE59006159D1 (de) | Verwendung von macrolactonen als antiallergica. | |
DE3850044D1 (de) | Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten. | |
IT1217177B (it) | Palmitoil-fruttosio-1,6-difosfato,suo uso terapeutico e relativi metodi di preparazione | |
RU93058426A (ru) | Антогонист галанина, способ его получения, пептид, фармацевтический состав и способ лечения | |
DE59008693D1 (de) | Gewebs-Plasminogen-Aktivator-Derivat. | |
IT1216535B (it) | O_(1,2_di_0_acetilglicero_3_fosforil)etanolamina, procedimento per la sua preparazione e suo uso terapeutico. | |
TH14318EX (th) | นิวคลีโอไซด์ที่ใช้ในการรักษาโรค | |
IT8819665A0 (it) | (1,2_di_0_acetil_glicero_3_fosforil)_colina, procedimento per la sua preparazione e suo uso terapeutico. | |
NO880831D0 (no) | Rekombinant human vevsplasminogen-aktivatorblanding. | |
GB8903389D0 (en) | Accessories for use by motorists and others such as ramblers,walkers and climbers |